Compounds > aspirin

aspirin and monocrotaline

aspirin has been researched along with monocrotaline in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ekins, S; Williams, AJ; Xu, JJ	1
He, B; Pu, J; Shen, J; Shen, L	1
Cheng, Y; Gao, H; Gong, B; Hu, J; Huang, L; Li, W; Liu, H; Qiao, C; Wang, X; Zhao, C; Zong, L	1

Other Studies

3 other study(ies) available for aspirin and monocrotaline

Article	Year
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Aspirin attenuates pulmonary arterial hypertension in rats by reducing plasma 5-hydroxytryptamine levels. Cell biochemistry and biophysics, 2011, Volume: 61, Issue:1 Topics: Animals; Aspirin; Blood Pressure; Body Weight; Disease Models, Animal; Heart Rate; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Serotonin; Survival Analysis	2011
Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway. Clinical and experimental hypertension (New York, N.Y. : 1993), 2017, Volume: 39, Issue:1 Topics: Animals; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Flavonoids; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; MAP Kinase Signaling System; Monocrotaline; Nitric Oxide Synthase Type III; Protein Kinase Inhibitors; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Systole; Vascular Remodeling	2017